|
⚲
|
| Keyboard |
| Peter Finn | |
|---|---|
| Firm | |
| Address | 53 State Sreet Boston, MA 02109 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| CeleCor Therapeutics Inc | 021-590216 | Executive Officer | 11.9 M of 15.0 M |
||
| Zetagen Therapeutics Inc | 021-536037 | Executive Officer | 12.9 M of 13.0 M |
||
| Zetagen Therapeutics Inc | 021-472735 | Executive Officer | 9.6 M of 15.0 M |
||
| Ambergen Inc | 021-442109 | Executive Officer | 5.0 M of 5.0 M |
||
| Celecor Therapeutics Inc | 021-436346 | Executive Officer | 45.5 M of 45.5 M |
||
| Celecor Therapeutics Inc | 021-398701 | Executive Officer | 1.0 M of 5.0 M |
||
| Vigeo Therapeutics Inc | 021-393558 | Executive Officer | 7.5 M of 17.5 M |
||
| Vigeo Therapeutics Inc | 021-393410 | Executive Officer | 7.6 M of 7.6 M |
||
| Cystetic Medicines Inc | 021-381436 | Executive Officer | 5.0 M of 25.1 M |
||
| Amylyx Pharmaceuticals Inc | 021-370064 | Executive Officer | 30.0 M of 30.0 M |
||
| Pulmoqune Therapeutics Inc | 021-365941 | Executive Officer | 5.5 M of 5.5 M |
||
| Amylyx Pharmaceuticals Inc | 021-356768 | Executive Officer | 14.8 M of 20.0 M |
||
| Zetagen Therapeutics Inc | 021-356559 | Executive Officer | 0.8 M of 8.5 M |
||
| Deepbiome Therapeutics Inc | 021-345244 | Executive Officer | 2.5 M of 4.9 M |
||
| Verispellis SKIS & Snowboards Inc | 021-329018 | Executive Officer | 0.3 M of 0.3 M |
||
| Zetagen Therapeutics Inc | 021-328871 | Executive Officer | 1.0 M of 1.0 M |
||
| Amylyx Pharmaceuticals Inc | 021-326193 | Executive Officer | 13.0 M of 13.0 M |
||
| Luna Pharmaceuticals Inc | 021-307753 | Executive Officer | 0.5 M of 1.0 M |
||
| Fusologics Inc | 021-305466 | Executive Officer | 1.7 M of 1.7 M |
||
| Amylyx Pharmaceuticals Inc | 021-292155 | Executive Officer | 1.8 M of 2.3 M |
||
| Platelet Biogenesis Inc | 021-287745 | Executive Officer | 10.0 M of 10.0 M |
||
| Celecor Therapeutics Inc | 021-285981 | Executive Officer | of 25.0 M |
||
| Luna Pharmaceuticals Inc | 021-273988 | Executive Officer | 1.8 M of 3.5 M |
||
| Amylyx Pharmaceuticals Inc | 021-269295 | Executive Officer | 4.1 M of 5.0 M |
||
| Platelet Biogenesis Inc | 021-267912 | Executive Officer | 1.1 M of 1.5 M |
||
| Amylyx Pharmaceuticals Inc | 021-251392 | Executive Officer | 1.4 M of 1.6 M |
||
| Artax Biopharma Inc | 021-250122 | Executive Officer | 3.0 M of 10.0 M |
||
| Vigeo Therapeutics Inc | 021-241663 | Executive Officer | 2.5 M of 10.0 M |
||
| AURA Biosciences Inc | 021-235305 | Executive Officer | 21.0 M of 34.5 M |
||
| Artax Biopharma Inc | 021-228000 | Executive Officer | 2.0 M of 2.0 M |
||
| AURA Biosciences Inc | 021-222909 | Executive Officer | 4.0 M of 4.0 M |
||
| AURA Biosciences Inc | 021-209519 | Executive Officer | 1.3 M of 1.3 M |
||
| Artax Biopharma Inc | 021-203505 | Executive Officer | 1.3 M of 2.0 M |
||
| AURA Biosciences Inc | 021-188934 | Executive Officer | 3.2 M of 3.2 M |
||
| Forma Therapeutics Holdings LLC | 021-183750 | Executive Officer | 10.0 M of 10.0 M |
||
| Intica Biomedical Inc | 021-175015 | Executive Officer | 1.0 M of 1.0 M |
||
| Forma Therapeutics Holdings LLC | 021-171988 | Executive Officer | 50.1 M of 50.1 M |
||
| AURA Biosciences Inc | 021-164993 | Executive Officer | 2.9 M of 2.9 M |
||